Colony Group LLC Bio Rad Laboratories, Inc. Transaction History

Colony Group LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 16, 2023	SELL	$418.69 - $503.0 $2,930 - $3,521	-7 Reduced 0.5%	1,380 $661,000
Q4 2022 Feb 14, 2023	SELL	$351.71 - $456.01 $157,214 - $203,836	-447 Reduced 24.37%	1,387 $583,000
Q3 2022 Nov 15, 2022	SELL	$412.59 - $563.26 $138,217 - $188,692	-335 Reduced 15.44%	1,834 $765,000
Q2 2022 Aug 16, 2022	SELL	$463.67 - $597.16 $9,273 - $11,943	-20 Reduced 0.91%	2,169 $1.07 Million
Q1 2022 May 16, 2022	BUY	$524.57 - $735.42 $680,891 - $954,575	1,298 Added 145.68%	2,189 $1.23 Million
Q4 2021 Feb 15, 2022	BUY	$708.84 - $794.68 $12,759 - $14,304	18 Added 2.06%	891 $673,000
Q3 2021 Nov 17, 2021	BUY	$657.71 - $825.77 $23,019 - $28,901	35 Added 4.18%	873 $651,000
Q2 2021 Aug 18, 2021	SELL	$576.64 - $649.04 $36,904 - $41,538	-64 Reduced 7.1%	838 $540,000
Q1 2021 May 21, 2021	BUY	$547.01 - $662.35 $247,795 - $300,044	453 Added 100.89%	902 $515,000
Q4 2020 Feb 16, 2021	BUY	$510.68 - $643.45 $229,295 - $288,909	449 New	449 $262,000

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.41B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Colony Group LLC, based on Form 13F filings with the SEC.

Stay updated on Colony Group LLC with notifications on news.